Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
about
Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@ast
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@en
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@nl
type
label
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@ast
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@en
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@nl
prefLabel
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@ast
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@en
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@nl
P2093
P2860
P1476
Safety and tolerability of doc ...... eptor 2-positive breast cancer
@en
P2093
Ellen B Kossoff
Ellis G Levine
Nuttapong Ngamphaiboon
Potjana Jitawatanarat
Tracey L O'Connor
P2860
P304
P356
10.4048/JBC.2014.17.4.356
P577
2014-12-26T00:00:00Z